Results 171 to 180 of about 17,066 (197)

Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis

Antioxidants, 2022
Pasquale Pignatelli, Isabella Russo, Francesca Santilli   +2 more
exaly  

Proprotein convertase 2

1998
Dietmar Schomburg, Dörte Stephan
openaire   +1 more source

Proprotein convertase 1

1998
Dietmar Schomburg, Dörte Stephan
openaire   +1 more source

Circulating Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Regulates VLDLR Protein and Triglyceride Accumulation in Visceral Adipose Tissue

Arteriosclerosis, Thrombosis, and Vascular Biology, 2011
Nabil Seidah, Katherine Cianflone, Zuhier Awan   +2 more
exaly  

Proprotein Convertase Subtilisin/Kexin Type 9 Interacts With Apolipoprotein B and Prevents Its Intracellular Degradation, Irrespective of the Low-Density Lipoprotein Receptor

Arteriosclerosis, Thrombosis, and Vascular Biology, 2012
Ningyan Zhang, Ba-Bie Teng, Zemin Yao
exaly  

Proprotein Convertases

2011
openaire   +1 more source

Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system

Journal of Neurochemistry, 2006
Nabil Seidah, David Baranowski, Annik Prat   +2 more
exaly  

Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia—Brief Report

Arteriosclerosis, Thrombosis, and Vascular Biology, 2016
Gilles Lambert, Livia Pisciotta, Barbara Sjouke   +2 more
exaly  

Proprotein Convertase Furin and Proprotein Convertase PC5/6

2013
openaire   +1 more source

The patient journey with proprotein convertase subtilisin/kexin type 9 inhibitors in community practice

Journal of Clinical Lipidology, 2019
, Ann Marie Navar, Robert J Sanchez
exaly